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ABSTRACT
Background: A hypothesis exists whereby an exercise- or dietary-
induced negative energy balance reduces human subcutaneous white
adipose tissue (scWAT) mass through the formation of brown-like
adipocyte (brite) cells. However, the validity of biomarkers of brite
formation has not been robustly evaluated in humans, and clinical
data that link brite formation and weight loss are sparse.
Objectives: We used rosiglitazone and primary adipocytes to strin-
gently evaluate a set of biomarkers for brite formation and determined
whether the expression of biomarker genes in scWAT could explain the
change in body composition in response to exercise training combined
with calorie restriction in obese and overweight women (n = 79).
Design: Gene expression was derived from exon DNA microarrays and
preadipocytes from obesity-resistant and -sensitive mice treated with rosi-
glitazone to generate candidate brite biomarkers from a microarray. These
biomarkers were evaluated against data derived from scWAT RNA from
obese and overweight women before and after supervised exercise 5 d/wk
for 16 wk combined with modest calorie restriction (w0.84 MJ/d).
Results: Forty percent of commonly used brite gene biomarkers
exhibited an exon or strain-specific regulation. No biomarkers were
positively related to weight loss in human scWAT. Greater weight
loss was significantly associated with less uncoupling protein 1
expression (P = 0.006, R2 = 0.09). In a follow-up global analysis,
there were 161 genes that covaried with weight loss that were linked
to greater CCAAT/enhancer binding protein a activity (z = 2.0, P =
6.63 1027), liver X receptor a/b agonism (z = 2.1, P = 2.83 1027),
and inhibition of leptin-like signaling (z = 22.6, P = 3.9 3 1025).
Conclusion: We identify a subset of robust RNA biomarkers for brite
formation and show that calorie-restriction–mediated weight loss in women
dynamically remodels scWAT to take on a more-white rather than a more-
brown adipocyte phenotype. Am J Clin Nutr 2016;104:557–65.
Keywords: browning, exercise, microarray, obesity, weight loss,
white adipose tissue
INTRODUCTION
There are $3 phenotypic versions of the adipocyte in mam-
mals (1, 2). The classic brown adipocyte, which originates from
a myogenic lineage (1, 3), can express high amounts of uncoupling
protein 1 (UCP1)9 and forms brown adipose tissue, which is a tissue
that is physiologically adapted for heat production through the un-
coupling of respiration. In contrast, white adipocytes are derived
from a lineage that is distinct from brown adipose tissue (4) and do
not typically express UCP1. Nevertheless, cells with biochemical
features of brown adipocytes can be present in white adipose tissue
(WAT) depots (5, 6), and these depots have been termed brite
(brown-in-white) or beige adipocytes (7). Brown and brite adipocytes
have the potential to increase energy expenditure (8) through the
activation of UCP1, and increased UCP1 messenger RNA (which is
a biomarker for brite or brown cells) is associated with a healthier
metabolic phenotype in obese humans (9). Thus, it has been pro-
posed that brite formation (with drugs) could be an effective treat-
ment of metabolic disease in humans. Although this concept is
appealing, the long-term efficacy of increasing brite formation will
depend on complex interactions between pharmacodynamics, appe-
tite, and energy balance. Exercise training can promote a loss of
body adipose tissue mass, and it has been proposed that this loss may
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be due to brite formation (10) and be part of the antidiabetic action of
exercise (11). Similar to the situation of a negative energy balance
encountered during cold stress in mice (12), it is plausible that the
neuroendocrine recruitment of UCP1 activity occurs after an exercise-
related negative energy balance. Nonetheless, to our knowledge,
there have not been any previous larger-scale clinical studies that
have confirmed this proposition, and the global molecular profile of
human adipose tissue after exercise training or weight loss has also
been understudied. To facilitate a successful pursuit of these con-
cepts, novel molecular targets to promote the formation of brite
cells and more-extensively validated biomarkers are required.
Rosiglitazone, which is a peroxisome proliferator–activated
receptor-g (PPARg) agonist (13), is one of the few drugs used in
humans that have been proven to generate brite adipocytes from
white preadipocytes and even from the most developmentally
white of adipose depots (epididymal) (2, 12), thereby suggesting
that the PPARg agonism is central to brite formation (14). Studies
of how rosiglitazone mediates brite formation from white pre-
adipocytes (2) have relied on a focused set of molecular markers
(15) with limited technical validation. To extend this work, we
used exon DNA microarray data (16) to better evaluate which
RNA biomarkers of brite formation are likely to be most useful.
Exon-based DNA microarray data have originated from mouse
strains with a differential propensity for obesity (Sv/129 and
C57BL/6). An analysis of the global transcriptome response to
rosiglitazone could also potentially identify non-PPARg ligands
that might also promote brite formation (17). We applied a subset
of stringent brite biomarkers to a large human study of sub-
cutaneous white adipose tissue (scWAT) before and after exercise
combined with modest calorie restriction to induce fat loss to
determine the relation between weight loss and the regulation of
genuinely stringent brite marker in vivo in humans.
METHODS
Human tissue and DNA microarray experiment data
Participants for our human study were from our previously
published Improving Diet, Exercise and Lifestyle for women
study (18, 19) (clinicaltrials.gov; NCT00710398) that was ap-
proved by the Research Ethics Board of the Hamilton Health
Sciences and conformed to the most-recent Canadian government
FIGURE 1 Characterization of the biology of the ROSI response between Sv/129 and C57BL/6 mice. (A) Mean6 SD RT-qPCR–derived expression changes
of adipogenesis marker Fabp4 and thermogenesis marker Ucp1; both genes were measured in inguinal white adipocytes originating from either Sv/129 or C57BL/6
mice, which were treated with or without ROSI and resulted in the following 4 groups: Sv/129 + ROSI, Sv/129 – ROSI, C57BL/6 + ROSI, and C57BL/6 – ROSI.
The response from both strains confirmed the induction of browning and the maturation of adipocytes. Each group is composed of n = 4. *Significance between
control and ROSI groups, P , 0.05. (B) Significance analysis of microarray was performed on Affymetrix Mouse Exon ST 1.0 (Affymetrix) with the use of RNA
independent from the RT-qPCR experiment (Sv/129 + ROSI: n = 4; Sv/129 – ROSI: n = 4; C57BL/7 + ROSI: n = 4; and Sv/129 – ROSI: n = 5) and identified
differentially expressed genes during brite formation in both strains. The gene lists from both strains were enriched in very similar pathways that were expectedly
associated with metabolism (and thus, the majority of the analysis henceforth relied on the combination of both strains). The black dotted line represents the
threshold for significance (B-H–corrected P = 13 1023). B-H, Benjamini-Hochberg–corrected; Fabp4, fatty acid binding protein 4; ROSI, rosiglitazone; RT-qPCR,
reverse transcriptase–quantitative polymerase chain reaction; Ucp1, uncoupling protein 1.
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tricouncil funding policy statement on the use of human subjects
in research. Biopsies were obtained from 85 overweight subjects
before and after 16 wk of exercise training coupled with an
w20% reduction in daily energy requirements of which 79
subjects had before and after body-composition measurements
and gene-chip data (Supplemental Table 1). The primary out-
come of this clinical study was to investigate the effect of dif-
ferent dairy and protein diets with exercise and showed that
higher protein, with high dairy, was modestly beneficial to body
composition in terms of a gain in lean mass and a loss of fat
mass (18, 19). Regardless of the diet group, in the current mo-
lecular analysis, the groups were combined.
Briefly, each subject trained for 5 d/wk under supervision and for 2
additional days unsupervised. Needle biopsies (taken with the use of
a 5-mm Bergstrom) were taken from scWAT just above the vastus
lateralis muscle of the quadriceps before and after the training in-
tervention. RNA was extracted with the use of an Agencourt
RNAdvance Tissue Kit (Beckman Coulter). A total of 300 ng was
amplified with the use of an Illumina TotalPrep-96 RNA amplification
kit (Life Technologies), hybridized to a HumanHT-12 V4.0 Expres-
sion BeadChip (Illumina), and scanned with the use of a BeadArray
Reader (Illumina) (at Nestle Research Center). Samples from 79
subjects passed standard quality-control methods. All microarray
analysis was carried out using R (version 3.2.2). Raw array data were
normalized with the use of quantile normalization, and detection calls
were used to filter the chip data (without background subtraction). A
median P value of 0.1 was used for detection rates across presamples
and postsamples, which left 18,747 genes in the analysis (yielding
a detected-gene count that was similar to the count in previous
studies). Quantitative significance analysis of microarrays [using the
SAMR package (Stanford University) in R, where the quantitative
option in false discovery rate (FDR) adjusted correlative model] was
implemented to generate a list of genes that vary in a positive or
negative manner with weight loss (FDR ,10%). Pearson correlation
coefficients were calculated independently. Microarray data were
deposited in the Gene Expression Omnibus database as GSE58559
(National Center for Biotechnology Information).
Cell culture, drug treatment, and RNA profiling
Subcutaneous inguinal preadipocytes were isolated fromSv/129
or C57BL/6 mice (Harlan) and processed as previously described
(20–22). Where indicated, cells were supplemented with or with-
out 1 mmol rosiglitazone maleate/L (Enzo Life Sciences) from the
first day of culture (20). RNAwas extracted on day 7 with the use
of TRizol solution (Life Technologies) as previously described (1).
RNA was dissolved in 20 mL RNAse-free water and stored at
2808C for subsequent analysis as previously described (16). Sets
of independent adipocytes cultures were produced for RNA for use
in the reverse transcriptase–quantitative polymerase chain reaction
(RT-qPCR) studies. A total of 500 ng total RNA was reversed
transcribed with a High-Capacity cDNA Reverse Transcription kit
(Life Technologies). Complementary DNA was diluted 1:5, and
FIGURE 2 Establishment of reliable brite markers. The Affymetrix Exon ST 1.0 (Affymetrix) arrays that were used for pathway enrichment (Figure 1B)
also provided exon-level changes that occurred with ROSI in detectable genes and were used to extract specific expression values corresponding to primers
used in de Jong et al. (15) to calculate the mean 6 SD percentage of change in expression in response to ROSI (n = 9) from the control (n = 8). All phenotypic
adipocyte markers except for Cidea [which is not a valid adipocyte subtype marker in humans (9)] were measured. Only phenotypic adipocyte markers that
reached significance are shown, whereas remaining phenotypic adipocyte-marker data are shown in Supplemental Figure 1A. $Expression changes from de
Jong et al. (15) are shown and were estimated from the original publication that used NMRI mice (15), which indicated that not all brite markers share the
same directionality across studies. Student’s unpaired t test was performed with the use of linear expression intensities. *,**,***Significance: *P , 0.05,
**P , 0.01, ***P , 0.001. Car4, carbonic anhydrase 4; Eva1; epithelial V-like antigen 1; Fbxo31, F-box protein 31; Fgf21, fibroblast growth factor 21;
Hoxc8, Homeobox C8; Hoxc9, Homeobox C9; Lhx8, LIM homeobox protein 8; NMRI, Naval Medical Research Institute; Pat2, proton/amino acid transporter
2; Prdm16, PR domain 16; P2rx5, purinergic receptor P2X 5; Ucp1, uncoupling protein 1; Zic1, zinc finger protein of the cerebellum 1.
FIGURE 3 Effects of 16 wk of exercise and dieting on body composi-
tion. Subjects from Josse et al. (18, 19) were all premenopausal and over-
weight or obese women, and an overview of clinical characteristics is shown
in Supplemental Table 2. Body-composition data (measured with the use of
dual-energy X-ray absorptiometry) from each subject (with complete biop-
sies and body-composition data) were compared before and after the inter-
vention and led to significant fat mass loss (A) and total body weight loss
(B). Data are shown for all subjects (n = 79). Each dot and its respective
connected dot represent data from a single subject. Student’s paired t test was
performed; ****P , 0.0001.
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1mL was added per well of the 384-optical well plates (Life
Technologies). Primers were mixed with SYBR Select Master Mix
(Life Technologies) and were run in triplicate. Thermal-cycling
conditions were 2 min at 508C followed by 2 min at 958C and 40
cycles of 15 s at 958C with 60 s at 608C on a ViiA 7 Real-Time
PCR System (Life Technologies). A eukaryotic 18S ribosomal
RNA kit (Life Technologies) was used as an input control, and
quantification relied on the Dcycle threshold method with primers
for Ucp1 and fatty acid binding protein 4 (Fabp4) as previously
described (20, 21).
Exon DNA microarray production
Twenty Affymetrix Murine Exon 1.0 ST arrays (Affymetrix)
were processed as previously described (16). Three samples were
excluded as outliers by normalized unscaled SE plots (supported
by a principal component analysis) before any downstream
statistical analysis was conducted. The raw data have been
deposited in the Gene Expression Omnibus database as GSE57903,
and these data have been used to develop a novel bioinformatic
method for analyzing gene splicing (16). An update of the annotation
of the exon array resulted in 16% of probes being removed because
of cross-hybridization at multiple genomic loci. Subsequently,
10% of probe sets were removed because the signal was approxi-
mately background across all samples. Finally, the remaining probe
sets (74% of all core probe sets) were mapped to a unique gene
identifier and significance analysis of microarrays was used to
estimate rosiglitazone-mediated differentially expressed genes in
Sv/129 and C57BL/6 cells. To allow for an accurate meta-
analysis of brite phenotypic adipocyte markers between our study
(Sv/129 or C57BL/6 mice) and published data from studies using
Naval Medical Research Institute (NMRI) mice (15), microarray
probe sets were selected to precisely match the regions spanned by
primers in thementioned study (15) by using the Primer-BLAST tool
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/).
Biological pathway analysis and upstream regulator
analysis
Regulated genes used for pathway and gene ontology analysis
need to be adjusted for technology and biological bias (23). To
partially address this, the group of regulated genes was contrasted
with all detectable genes in the experiment (and not with all genes
on the gene chip or in the network database). An ingenuity pathway
analysis (IPA) was used to identify potential upstream regulators of
the regulated gene list, whereby regulated and background de-
tectable genes were mapped to an IPA database (17). We used an
upstream analysis whereby a P value was generated on the basis
FIGURE 4 Evaluation of reliable brite markers and ROSI-regulated genes
in white adipose tissue in response to exercise and dieting. HumanHT-12 V4.0
Expression BeadChip (Illumina) were used to measure gene-expression changes
in 79 individuals before and after a 16-wk intervention. The data set was used to
extract mean 6 SD linear expression intensities corresponding to brite markers
(A) that were consistent across Sv/129, C57BL/6, and NMRI mice, but no
changes were shown. Note that CA4 is the human ortholog of Car4. ROSI-
regulated genes were measured in human subcutaneous white adipose tissue,
but neither the most-upregulated ROSI genes (B) nor the most-downregulated
ROSI genes (C) changed with intervention. Note that not all ROSI-responsive
genes identified in mice had one-to-one orthologs, and certain Illumina probes
hit multiple genomic regions, and thus, genes that fall into either of these cate-
gories were not included. n = 79 paired samples. Student’s paired t test was
performed with the use of linear expression intensity (AU), but no significance
was shown. B3GALT2, beta-1,3-galactosyltransferase 2; CA4, carbonic an-
hydrase 4; CIDEC, cell death inducing DFFA like effector c; ELOVL3, fatty acid
elongase 3; EVA1, epithelial V-like antigen 1; FABP3, fatty acid binding protein 3;
FGF21, fibroblast growth factor 21; GABRE, gamma-amiobutyric acid type A
epsilon subunit; GYS2, glycogen synthase 2; HPSE, heparanase; HSD11B1, hy-
droxysteroid 11-beta dehydrogenase 1; IL6, interleukin 6; IL1RL1, interleukin 1
receptor like 1; LHX8, LIM homeobox 8; NAT8L, N-acetyltransferase 8 like;
NMRI, naval medical research institute; PAT2, proton/amino acid transporter 2;
PRDM16, PR domain containing 16; P2RX5, purinergic receptor P2X 5; ROSI,
rosiglitazone; SERPINB2, serpin family B member 2; SLC16A3, solute carrier
family 16 member 3; SPTLC3, serine palmitoyltransferase, long chain base
subunit 3; UCP1, uncoupling protein 1.
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of the degree of overlap between a given gene set within the IPA
database (which typically reflects the published gene changes in
response to a range of transcription factors or drugs) and the
differentially expressed genes in the current data. After adjusting
for the data-set size, a Fisher’s exact test was applied. A second
variable [activation or inhibition (z score)] was used to compare
the directional change in the experimental gene set compared with
in the IPA database. The z score informed on whether the
upstream regulators were likely to be active or inhibited. A z score
.2 and a robust P value (e.g., P , 1 3 1023 or better) were
required to consider an association as being significant and, thus,
potentially of biological interest.
Statistical analysis
All nonmicroarray statistics were carried out with the use of
GraphPad Prism software (version 6.0; GraphPad Software). For
the RT-qPCR analysis, a Mann-Whitney U test was performed
with the use of a Dcycle threshold value between the control group
and the rosiglitazone group. For the murine analysis, an unpaired
t test was performed with the use of linear-expression values from
exon-specific probe sets between control and rosiglitazone groups.
For the human analysis, a paired t test was performed on values of
total body weight, fat mass, and linear expression from probe sets
before and after the intervention. Pearson correlation coefficients
were derived between the change in weight and the change in
gene expression with the intervention.
RESULTS
The rosiglitazone treatment resulted in substantial differential
gene expression (Supplemental List 1). In C57BL/6-derived
white adipocytes, the rosiglitazone treatment resulted in 1270
and 736 genes being upregulated and down regulated, re-
spectively. In Sv/129 adipocytes, 833 and 308 genes were up-
regulated and downregulated, respectively. RT-qPCR validation
confirmed similar Fabp4- and Ucp1-expression changes in both
strains (Figure 1A) and the expected pathways that are associ-
ated with lipid metabolism and substrate oxidation in both
strains (Figure 1B). An upstream analysis (Supplemental Table 2)
showed that both Sv/129 and C57BL/6 gene lists were dominated
by an extremely strong rosiglitazone-related transcriptional sig-
nature (Sv/129: z = 5.8, P = 1.2 3 10223; C57BL/6: z = 6.5, P =
3.7 3 10230) that was consistent with a PPARg-activation sig-
nature (Sv/129: z = 5.7, P = 1.63 3 10225; C57BL/6: z = 5.9, P =
4.16 3 10229). This analysis provided robust experimental vali-
dation of the upstream-analysis method for subsequent use with
the human clinical data.
Various brite phenotypic biomarkers along with other genes
measured by de Jong et al. (15), which relied on NMRI mice,
were shown to be w60% consistent with Sv/129 and C57BL/6
FIGURE 5 Relation between brite markers or rosiglitazone-responsive genes with combined exercise- and diet-induced weight loss. Of the 22 genes that
were assessed (Figure 4) only UCP1 (P = 0.006, R2 = 0.09) (A) and NAT8L (P = 0.003, R2 = 0.11) (B), a brite marker and a rosiglitazone up-regulated gene,
respectively, showed a significant correlation between weight loss and a gene-expression change. In addition, both of these correlations went in the opposite
direction because they both decreased with weight loss, which was the opposite effect if brite formation occurred. Another popular gene that is associated with
brite formation is FGF21 (P = 0.89, R2 = 0.0002) (C), but it showed no link with weight loss, whereas TNFRS21 (P , 0.0001, R2 = 0.23) (D), which was
identified with the use of quantitative significance analysis of microarray along with 180 other genes, showed a much-stronger correlation, implying that
molecular changes are occurring with weight loss and are not linked to brite formation, at least in human subcutaneous white adipose tissue. A Pearson
correlation was carried out between the change in linear expression intensity (AU) and the percentage of change in weight loss from paired samples with the
use of subjects considered in the creation of Figure 4 (n = 79), and significance was determined at P , 0.05. FGF21, fibroblast growth factor 21; NAT8L,
N-acetyltransferase 8 like; TNFRSF21, tumor necrosis factor receptor superfamily, member 21; UCP1, uncoupling protein 1.
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mice (Supplemental Table 3). In our study, 12 of the bio-
markers were significantly altered with rosiglitazone, but not all
biomarkers were regulated in the same direction as noted in
NMRI mice [e.g., homeobox C9 (Hoxc9), F-box protein 31
(Fbxo31), zinc-finger protein of the cerebellum 1 (Zic1), and
homeobox C8 (Hoxc8) (in the current study, Zic1 decreased with
rosiglitazone] (Figure 2). Several additional phenotypic marker
genes did not respond to rosiglitazone, including cluster of dif-
ferentiation 137 (Cd137), transmembrane protein 26 (Tmem26),
and cbp/p300-interacting transactivator 1 (Cited1) (Supplemental
Figure 1A) indicating that they may be markers of cell origin. In
addition, the exon-specific RNA profiling of LIM homeobox 11
(Lhx8), purinergic receptor P2X 5 (P2rx5), and alanine-serine-cysteine
1 (Asc1) showed that an interpretation of rosiglitazone’s effects
was dependent on which exon was selected for the RT-qPCR
analysis (Supplemental Figure 2). An analysis of house-keeping
gene responses across strains (15) showed that this dependence
did not explain differences across studies (Supplemental
Figure 1B).
The stringent biomarker genes, which reflected the exon-level
analysis of the in vitro brite-formation studies, were checked to
ensure comparability with the 3# end of the same transcripts
(data not shown) because the responses of these genes in human
scWAT were measured with the use of a standard 3# DNA mi-
croarray. As previously published (18, 19), there were substantial
improvements in body composition after this gold-standard life-
style intervention with a loss of fat mass (24.4 6 2.8 kg; P ,
0.0001) and total body mass (24.4 6 3.5 kg; P , 0.0001)
(Figure 3). However, we showed no evidence for the positive
regulation of any brite marker gene in human scWAT in response
to exercise and dieting (P . 0.05) (Figure 4A).
In addition, the human adipose tissue gene-expression re-
sponse to exercise training and calorie restriction was not related
to the pattern of rosiglitazone-regulated genes (Figure 4B, C).
When we correlated the extent of weight loss with changes in
selected brite markers or rosiglitazone-regulated genes, we
showed that UCP1 (P = 0.006, R2 = 0.09) (Figure 5A) and
N-acetyltransferase 8 like (NAT8L) (P = 0.03, R2 = 0.11) (Figure
5B) were decreased with greater weight loss (i.e., the opposite
direction that was expected if brite formation was occurring),
whereas fibroblast growth factor 21 (FGF21) showed no cor-
relation (Figure 5C).
An unbiased DNA microarray analysis of human scWAT in
response to the intervention showed 155 RNAs were positively
correlated with weight loss and 26 RNAs were negatively cor-
related with weight loss (FDR ,10%) (Supplemental List 2).
An example of a gene that was univariately correlated with
weight loss (TNFRSF21) is shown in Figure 5D (R2 = 0.22, P ,
0.0001). After uploading the 181 genes and the detected back-
ground genes into the IPA database (Supplemental List 3), 161
genes were available for analysis. These weight-loss–correlated
genes showed enrichment in the expected pathways such as lipid
metabolism (Supplemental Figure 3) as well as evidence for
dynamic tissue remodeling including adipogenesis rather than
a simplistic atrophy of adipose tissue mass (Supplemental Ta-
ble 4). For instance, we showed evidence for CCAAT/enhancer
binding protein a (C/EBPa) activation (z = 2.0, P = 6.63 1027)
that was indicative of adipogenesis (Figure 6). We also noted
a marginal result of interest (less than the stated z = 2 threshold)
[i.e., adenosine A2 activation (z = 1.9, P = 7.9 3 1024)] up-
stream of some of the transcriptional responses in scWAT during
weight loss. More-robust results included evidence for liver X
receptor a/b (LXRalpha/b) agonism (z = 2.1, P = 2.8 3 1027) and
the inhibition of leptin-like signaling (z = 22.6, P = 3.9 3 1025).
DISCUSSION
In the current study, we discovered that UCP1 expression was
negatively correlated with weight loss in humans in response to
exercise training combined with modest energy restriction. Our
data appear to rule out the hypothesis that exercise promotes
weight loss through brite formation (10) at least in women and
when a negative energy balance is induced via a combination of
strategies. The study of the molecular drivers that regulate the
WAT phenotype, including the promotion of the formation of
brite adipocytes, is a complex process that requires both in vitro
and in vivo models (24). Brite formation has been proposed as
a mechanism to increase the metabolic rate to promote weight
loss in obese subjects (10). Several factors limit the progress
toward the testing of this hypothesis including a lack of novel
drugs to stimulate brite formation. In addition, knowledge of
reliable biomarkers for brite formation that are consistent in
both preclinical and clinical models are needed (i.e., for drug-
development studies).
FIGURE 6 Upstream regulatory analysis of weight-loss–associated
genes identified strong C/EBPa activation. With the use of 161 genes that
were correlated with weight loss, their respective Pearson correlation co-
efficients were used in an ingenuity pathway analysis: upstream analysis,
which identified potential regulators that either are responsible or mimic the
effect of exercise- and diet-induced weight loss (Supplemental Table 4). A
strong activation of C/EBPa (z score = 2, P = 6.6 3 1027) occurred, which
led to numerous downstream signalings that ultimately affected adipogenesis.
*Significantly regulated by C/EBPa in multiple species. ACACA, acetyl-CoA
carboxylase alpha; ACLY, ATP citrate lyase; AGPAT2, 1-acylglycerol-3-phosphate
O-acyltransferase 2; AKR1C3, aldo-keto reductase family 1, member C3; APLNR,
apelin receptor; CEBPA, CCAAT/enhancer binding protein a; C/EBPa, CCAAT/
enhancer binding protein a; EPHX1, epoxide hydrolase 1; LEP, leptin; NRP1,
neuropilin 1; PGD, phosphogluconate; PPL, periplakin; SCD, stearoyl-CoA desa-
turase; SERPINI1, serpin family I member 1; TUBB2A, tubulin beta 2A class IIa;
VCL, vinculin.
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The upstream analysis showed that rosiglitazone-treated cells
displayed a clear pattern of gene expression that reflected PPARg
agonism (Supplemental Table 2). We also showed that the rosi-
glitazone transcriptional signature was strongly linked to mono-
(2-ethylhexyl)phthalate (MEHP) activity (z = 5.6, P = 2.7 3
10231). An environmental obesogen, MEHP originates from plas-
tics and, after either in vitro or in utero exposure, promotes adi-
pogenesis (25). The impact of MEHP on brite formation is
unknown, but the presence of this common environmental factor
complicates the interpretation of UCP1 expression analyses in adult
humans. Mimicking global aspects of PPARg agonism, MEHP has
a PPAR co-activation activity (26, 27). Although phthalate me-
tabolites have been associated with increased diabetes risk, MEHP
has not (28), which suggests that a greater understanding of the
molecular actions of MEHP may yield insight into how to safely
promote brite formation.
We were able to identify a number of compounds that partially
overlap with the brite gene-expression program. The P38
mitogen-activated protein kinase inhibitor SB203580 was signif-
icantly associated with the rosiglitazone signature (z = 4.69, P =
6.8 3 10214) as was PD98059, which is an indirect extracellular
signal-regulated kinase 1/2 (ERK1/2) inhibitor (z = 6.15, P = 2.1 3
10212). Holstrom et al. (29) showed that Erk1/2 activation was
involved in the initial proliferation response in brown pre-
adipocytes. U0126, which is another indirect inhibitor of ERK1/2,
which also appeared important for activating an adipogenic
program in human mesenchymal stem cells (30). The global
rosiglitazone transcriptional signature also overlapped with
mitogen-activated protein kinase kinase kinase kinase 4
(MAP4K4) inhibition (z score = –5.05, P = 4.8 3 10227).
MAP4K4 was subject to a drug-discovery effort, and the si-
lencing of Map4k4 induces Myf5, which is a developmental
muscle and brown-adipocyte cell marker (31). We suspect that it
is unlikely that MAP4K4 inhibitors have a sufficient safety
profile to represent a chronic strategy for promoting brite for-
mation (32). However, single-target drugs for complex chronic
diseases are also unlikely, and it would be more appealing to
consider combinatorial therapy options, e.g., combined ERK
activation and MAP4K4 inhibition targeting distinct compo-
nents of the rosiglitazone RNA-expression program.
Although a variation in the extent of the browning response in
different scWAT depots is accepted, the issue of variation can be
extended by consideration of both the genetic background (33)
and transcript variants (the exon targeted for RT-qPCR) of each
phenotypic marker. Some phenotypic markers have an unclear
biological role during browning, whereas some markers such as
Fgf21 are thought to actively influence thermogenesis (34). The
adipocyte markers described in the current study are represen-
tative of markers that have been commonly used in literature
(15). One recent study claimed to determine the stringency of
brite markers with the use of NMRI mice (15). We revisited
these data (15) (Supplemental Table 3), and in general terms
(directionality), there was only an w60% agreement between
studies. Although the use of different messenger RNA quanti-
fication methods (RT-qPCR compared with microarray) can
introduce differences, exon arrays allowed us to match the exon
and housekeeping-gene analyses across studies (Supplemental
Figure 1B). However, with the use of a subset of stringent brite
biomarkers, we showed no regulation in adipose women in
a negative–energy-balance state. The current repertoire of
murine-derived phenotypic adipocyte markers may need to be su-
perseded by human studies; however, efforts to profile human
adipose tissue (35) must control for the presence of contami-
nating cell types (i.e., blood, blood vessels, and nerves). There
are also limitations of our in vitro models (2, 20, 21) because we
do not fully capture the complexity of brite formation or adipose
tissue dynamics in vivo, and thus, specific markers in the context
of an in vitro system can become nonspecific in a human tissue
biopsy.
Increasingly, it has become accepted that chronic exercise
training should alter the phenotype of adipose tissue and not just
reduce its mass (10). If exercise training induced greater UCP1
activity, this effect might represent a counterintuitive increased
capacity for heat generation (rather than dissipation). In contrast,
excessive adipose tissue loss reduces the role of human adipose
tissue in thermal insulation, and perhaps a greater thermogenic
capacity would have been beneficial for survival (but now we
have clothes and central heating). Nevertheless, we observed that
human scWAT samples did not show signs of browning with 16 wk
of exercise training despite marked improvements in fitness,
fat loss, and the identification of specific molecular programs that
are related to the remodeling of adipose tissue. We noted a de-
crease in UCP1 expression with weight loss, which was perhaps
an adaptive response (whitening) that reflected reduced calorie
intake or a negative energy balance. We note that UCP1 ex-
pression can be lower in leaner individuals (9), which suggests
that our finding is not paradoxical, at least in humans. However,
a potential limitation of this study was the lack of a comparative
energy-restriction-only group to determine the contribution of
reduced calorie intake on scWAT. In addition, our study con-
sisted of women, and we only assessed one scWAT region.
Emerging studies on WAT biology have been primarily focused
on understanding mechanisms that transform WAT to energy-
dissipating tissue (10). However, a greater understanding of mo-
lecular adaptations concomitant with weight loss will provide
insights in understanding WAT plasticity and health. The loss in
adipose mass with exercise has been commonly reported to reflect
reduced adipocyte size (36), and whether the adipocyte number
changes is not often reportedwith exercise. Our molecular network
analysis showed evidence that there was increased C/EBPa ac-
tivity in the tissue, which was concurrent with exercise- and diet-
induced weight loss, and such activity is typically associated with
adipogenesis. Therefore, it would seem that our intervention may
have increased adipocyte turnover because the total adipocyte
number remains roughly stable with weight loss (37).
We showed evidence for the inhibition of local adipose leptin
signaling as well as LXRa/b agonism. Previous studies have
showed that, when human white adipocytes are treated with an
LXR agonist, there is an increased lipolysis and b oxidation
(38). With the use of an IPA, we identified an intriguing overlap
with 11 genes that we previously showed (39) were related to
the ability to remodel the cardiovascular capacity, thereby sug-
gesting that these adaptability genes may influence the potential
to remodel multiple tissue (4 11 genes; Benjamini-Hochberg–
corrected P = 5 3 1023).
In conclusion, with the use of a genuinely stringent repertoire
of brite biomarkers in human scWAT samples, 16 wk of exercise
training with calorie restriction does not result in increasedUCP1
expression or of any other brite biomarker despite evidence for
the molecular remodeling of adipose tissue.
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